The D.C. federal prosecutor's office is investigating allegations that local police manipulated crime data to create a false sense of safety, amid claims that crime numbers were faked to appear lower, despite official reports showing a 30-year low in violent crime in 2024. Former Fox News host Jeanine Pirro, leading the investigation, and local police union officials have raised concerns about data manipulation, while Trump has publicly accused D.C. officials of falsifying crime statistics to deceive the public.
The article discusses concerns over potential manipulation of US economic data, drawing parallels with Greece and Argentina's past falsification of economic figures, and emphasizes the importance of credible government data for global markets. Despite political tensions, experts believe the US's economic size and data quality are currently robust, but warn of risks from revisions and budget cuts to data collection.
President Donald Trump nominated E.J. Antoni, a critic of the BLS, as the new commissioner after firing the previous one, Erika McEntarfer, amid controversy over alleged data manipulation and concerns about the bureau's credibility and data reliability.
The US economy faces trust issues following doubts cast on government data accuracy by President Trump, a weak jobs report, and the resignation of a Fed governor, leading to market volatility and concerns over political influence on economic data and policy decisions.
A study published in The Lancet reveals that nearly half of over 200 US government health datasets were altered without proper disclosure, raising concerns about data integrity and its impact on public health research, especially regarding sensitive terms like 'gender' and 'sex'. The timing and focus of these edits suggest possible political motives, highlighting the need for better transparency and version control in federal data management.
Japan's transport ministry raided Toyota's headquarters amid a scandal over manipulated safety data, affecting the world's largest carmaker and other Japanese automakers like Honda, Mazda, and Suzuki. Toyota has suspended production of three models and apologized for neglecting proper certification processes. The scandal has led to inspections of other carmakers and halted shipments and production in some cases.
A former Colorado Bureau of Investigation forensic scientist, Yvonne "Missy" Woods, manipulated DNA test results in hundreds of cases from 2008 through 2023, prompting further investigation into her work dating back to 1994. While the bureau did not find that she falsified DNA matches or fabricated DNA profiles, 652 cases were affected by her data manipulation. A separate criminal investigation into Woods is ongoing, and the CBI is conducting an audit of all DNA analysts to ensure the accuracy and completeness of its records.
A former Colorado Bureau of Investigation DNA analyst, Yvonne “Missy” Woods, intentionally manipulated data in the testing process for at least 15 years, affecting 652 cases between 2008 and 2023. An internal affairs investigation found that Woods omitted material facts, tampered with DNA testing results, and violated lab policies. While she did not falsify DNA matches, her actions called into question the reliability of her testing. A separate criminal investigation is ongoing, and the CBI is implementing changes to enhance the integrity of its testing processes and prevent similar issues in the future.
A former Colorado Bureau of Investigation DNA scientist, Yvonne "Missy" Woods, is under investigation for manipulating data and not following standard testing protocols, raising questions about hundreds of criminal cases she processed evidence for from 2008 through 2023. The agency is reviewing all her previous work for data manipulation, and investigators have found 652 affected cases so far. The Colorado Department of Public Safety has requested $7.5 million for retesting DNA samples and potential reprosecution of affected cases, while a criminal investigation of Woods is underway.
The Colorado Bureau of Investigation (CBI) conducted an internal investigation into a former DNA scientist, Yvonne "Missy" Woods, and found that she manipulated data and posted incomplete test results in DNA testing processes. The investigation revealed that Woods omitted facts in official criminal justice records and tampered with DNA testing results, impacting 652 cases between 2008 and 2023. The CBI is conducting a comprehensive audit of all DNA analysis to ensure the accuracy and completeness of its records and is implementing process and procedural changes to enhance the integrity of its testing processes.
Data sleuths have uncovered widespread data manipulation in cancer research papers published by leading researchers at the Harvard-affiliated Dana-Farber Cancer Institute, prompting retractions and internal investigations. The manipulations involved blatant fraud, including reused images, copied and pasted test results, and identical data plots on different days. This issue is not new, as a 2016 study found that 3.8% of biomedical papers showed signs of image manipulation. The fact that external sleuthing was required to uncover these cases is troubling, as is the lack of institutional processes to review papers. The discovery of these challenges at Harvard University has brought public attention to the issue, and it is hoped that this will spark change in the field of biomedical research.
A 2021 cancer study by Dr. Sam Yoon was quietly withdrawn due to severe data problems, and it was later revealed that this was part of a pattern, with 26 articles containing suspect data. Dr. Yoon, chief of a cancer surgery division at Columbia University, and a junior researcher are under investigation, and a medical journal has retracted one of their articles. The lack of transparency around data problems in scientific publishing is highlighted by this case.
The Dana-Farber Cancer Institute is retracting six papers and correcting 31 others authored by four senior researchers following allegations of data manipulation. The corrections come after claims of misconduct against DFCI President and CEO Laurie H. Glimcher ’72, Executive Vice President and COO William C. Hahn ’87, Senior Vice President for Experimental Medicine Irene M. Ghobrial, and Harvard Medical School professor Kenneth C. Anderson. The institute's research integrity officer stated that they are committed to a culture of accountability and integrity and are examining every inquiry about research integrity fully.
Dana-Farber Cancer Institute is facing allegations of data manipulation in research papers authored by four of its top scientists, including CEO Laurie Glimcher and COO William Hahn. An investigation has been ongoing for over a year, with potential retractions and corrections being considered for several papers. The institute's research integrity officer confirmed that the allegations are credible and warrant further examination, while emphasizing that the presence of image discrepancies does not necessarily indicate misconduct. The institute is committed to a thorough review of the original data and taking appropriate corrective actions.
Dana-Farber Cancer Institute is in the process of retracting one paper and correcting others following an investigation into manipulated data, involving numerous papers authored by top scientists and institute leaders, including CEO Laurie Glimcher and COO William Hahn. The review process began over a year ago, and while not all claims have been reviewed, several are serious enough that discussions with journals about retractions and corrections are underway, with none of the allegations dismissed for lack of scientific merit so far.
